Last updated 2026-06-18
- Went public (IMCC), Oct 2019
- Acquired Blackaxe Technologies, Mar 2026
- Acquired Oranim Pharm, Mar 2022
Total raised
$68.0M
Last: 2026-06
Stage
Public
Founded
2008
Headcount
15
HQ
Glil Yam, Israel
Sector
Health Tech & Life Sciences
About
IMC is an international cannabis company that provides premium cannabis products to medical patients in Israel and Germany, two of the largest medical cannabis markets. The Company leverages a transnational ecosystem powered by a unique data-driven approach and a globally sourced product supply chain.
Funding history · 13 rounds · $68.0M total
2026-06
$225K
2026-06
$225K
2026-05
$550K
2025-07
$4.1M
2025-07
$1.0M
2024-11
$2.1M
2023-10
$950K
2023-01
$6.7M
2023-01
$2.0M
2022-10
$3.0M
2022-08
$5.0M
2021-05
$35.0M
2018-05
$9.1M
Q&A
- What was IM Cannabis's most recent funding round?
- In June 2026, IM Cannabis raised $225,000 in a convertible note financing round.
- What was the total amount of funding IM Cannabis has raised to date?
- IM Cannabis has raised a total of $68,000,000 USD.
- When did IM Cannabis go public on NASDAQ?
- IM Cannabis's common shares were expected to begin trading on NASDAQ on March 1, 2021, as part of an IPO.
- What is the current employee count for IM Cannabis?
- IM Cannabis has 11-50 employees.
- What was a significant acquisition made by IM Cannabis in 2026?
- In March 2026, IM Cannabis acquired Blackaxe Technologies.
- What strategic move did IM Cannabis announce in June 2026 regarding its European activities?
- In June 2026, IM Cannabis Corp. entered into a Letter of Intent to sell its European activities, expecting to significantly reduce debt by CAD$10.5 million.
- What was a key financial result reported by IM Cannabis in March 2026?
- In March 2026, IM Cannabis reported 2025 results with revenue of C$54.7 million, over 134% growth in Germany, and positive operating cash flow.
- What was a notable board change announced by IM Cannabis in January 2026?
- In January 2026, IM Cannabis announced the appointment of Mr. Alon Dayan to its Board of Directors.
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyMedical Cannabis
Technologies
BiologicalsHerbals
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B
Tags
medical-cannabis
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | imcannabis.com/ |
|---|---|
| linkedin.com/company/imc-israel |
Identifiers & details
| Founded | 2008-1 |
|---|---|
| Employees (exact) | 15 |
| Market cap | $1.8M |
| Status reason | Public on CSE on Oct 2019;Public on NASDAQ on Mar 2021; |
Acquisitions & public offerings
| Acquired | Date | Amount |
|---|---|---|
| Blackaxe Technologies | 2026-03 | |
| Oranim Pharm | 2022-03 | |
| MYM Nutraceuticals | 2021-04 | |
| Trichome Financial | 2021-03 |
| Type | Date | Exchange | Ticker | Amount |
|---|---|---|---|---|
| 2021-03 | IMCC | |||
| 2019-10 | IMCC |
Radar intelligence
Web history (Wayback)
| Domain | imcannabis.com |
|---|
Certificate / subdomain footprint
| Subdomains | 8 |
|---|